Catalyst Pharmaceutical
CPRX
CPRX
97 hedge funds and large institutions have $193M invested in Catalyst Pharmaceutical in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 99 → 97 (-2)
3.07% less ownership
Funds ownership: 52.82% → 49.75% (-3.1%)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
Holders
97
Holding in Top 10
1
Calls
$928K
Puts
$458K
Top Buyers
| 1 | +$4.17M | |
| 2 | +$1.26M | |
| 3 | +$990K | |
| 4 |
BlackRock
New York
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$699K |
Top Sellers
| 1 | -$6.19M | |
| 2 | -$5.58M | |
| 3 | -$2.73M | |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$1.52M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.27M |